How heavy do you have to be to get Mounjaro?

Is your BMI in the licensed range, and how to check in under a minute?

The UK licence for Mounjaro sets the primary threshold at a BMI of 30 or above, which covers most definitions of obesity. If your BMI sits between 27 and 29.9 (a range often described as overweight rather than obese) you may still qualify, but only if you also have at least one weight-related health condition that treatment could improve. Neither threshold is a perfect measure of health; BMI says nothing about where you carry weight, your muscle mass or your metabolic risk. What it does is give a prescriber a starting point.

You can use the NHS BMI calculator to find your number before your consultation. It takes about 45 seconds. Knowing it in advance means your clinical review can move faster, because your prescriber spends less time on basics and more time on the nuances of your case.

For people from South Asian, Chinese, Middle Eastern, Black African or African-Caribbean backgrounds, UK guidance recognises that health risks arise at lower BMI values. Thresholds are set 2.5 kg/m² lower across the board, so the equivalent entry points become approximately 27.5 and 24.5 respectively. This is not a workaround; it reflects published evidence on how BMI relates to cardiometabolic risk across different populations.

None of this replaces a prescriber's judgment. If you are unsure whether your starting point meets the criteria, our guide on how heavy you need to be to get Mounjaro walks through the thresholds in plain terms. For more on how tirzepatide works and who it is designed for, the tirzepatide overview on this site sets out the background.

What weight-related conditions count, and why they change the calculation?

The conditions that expand eligibility below BMI 30 are those where excess weight is a direct driver of the condition or makes it significantly harder to manage. The UK licence specifically names type 2 diabetes (or prediabetes in some assessments), hypertension, dyslipidaemia (raised cholesterol or triglycerides), obstructive sleep apnoea and, in some clinical contexts, osteoarthritis or cardiovascular disease.

These are not boxes to tick on a form. A prescriber looks at whether your condition is active, documented, and whether weight reduction could meaningfully improve it. Someone with well-controlled blood pressure on medication is in a different clinical position from someone whose blood pressure is rising despite lifestyle changes. Both may qualify; the clinical reasoning differs.

NICE's appraisal of tirzepatide, published as TA1026, sets a higher bar for NHS prescribing (BMI 35 or above, plus at least one condition) because NHS funding criteria are deliberately more conservative than the medicine's licensed indications. Private prescribing follows the licence, so the conversation about eligibility at a private service like nume covers a wider group than the NHS pathway currently does. If you are weighing up those routes, the Mounjaro cost guide sets out what private treatment typically involves financially.

Age matters too. The licence covers adults only. If you have questions about the minimum age requirement, the age eligibility page covers this in full.

What the prescriber looks at beyond the BMI figure?

Meeting the BMI and condition thresholds opens the door to a consultation. It does not close the clinical assessment. A prescriber working responsibly (which is what the GPhC register exists to enforce) will look at contraindications and cautions before approving treatment.

A history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2) rules out tirzepatide. A personal history of pancreatitis warrants careful discussion. Certain gastrointestinal conditions, recent major surgery, and a range of existing medicines may affect whether Mounjaro is the right choice or whether the dose schedule needs adjusting. Pregnancy and breastfeeding are clear contraindications; if you are also noticing changes to your cycle during treatment, our page on heavy periods on Mounjaro explains what is known and when to seek advice. The medicine is also not recommended for anyone actively trying to conceive.

At nume, every consultation is read by a GPhC-registered Independent Prescriber on the day it is submitted. Not software, not a standard form review, a clinician reads your answers, checks for relevant interactions and flags anything that needs follow-up before any prescription is issued. That is the part of the process that turns a BMI number into a genuine clinical decision. You can read more about how that team works on the clinical team page.

If you want a broader look at the weight-management options available through nume (including how Mounjaro sits alongside other licensed treatments) the weight loss treatments overview is a useful starting point before your consultation. For a concise summary of the specific figures involved in qualifying, the page covering what weight you have to be to get Mounjaro brings together the key numbers in one place.